Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug Screening for ALS Using Patient-Specific Induced Pluripotent Stem Cells
Naohiro Egawa, Shiho Kitaoka, Kayoko Tsukita, et al.
Science Translational Medicine (2012) Vol. 4, Iss. 145
Closed Access | Times Cited: 520

Showing 1-25 of 520 citing articles:

Induced pluripotent stem cell technology: a decade of progress
Yanhong Shi, Haruhisa Inoue, Joseph C. Wu, et al.
Nature Reviews Drug Discovery (2016) Vol. 16, Iss. 2, pp. 115-130
Open Access | Times Cited: 1315
Human iPSC-Based Modeling of Late-Onset Disease via Progerin-Induced Aging
Justine D. Miller, Yosif Ganat, Sarah Kishinevsky, et al.
Cell stem cell (2013) Vol. 13, Iss. 6, pp. 691-705
Open Access | Times Cited: 713
TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS
Chien‐Hsiung Yu, Sophia Davidson, Cassandra R. Harapas, et al.
Cell (2020) Vol. 183, Iss. 3, pp. 636-649.e18
Open Access | Times Cited: 702
ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?
Rita Mejzini, Loren L. Flynn, Ianthe Pitout, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 655
Pluripotent stem cells in disease modelling and drug discovery
Yishai Avior, Ido Sagi, Nissim Benvenisty
Nature Reviews Molecular Cell Biology (2016) Vol. 17, Iss. 3, pp. 170-182
Closed Access | Times Cited: 551
ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair
Joseph R. Klim, Luis A. Williams, Francesco Limone, et al.
Nature Neuroscience (2019) Vol. 22, Iss. 2, pp. 167-179
Open Access | Times Cited: 491
Pathways Disrupted in Human ALS Motor Neurons Identified through Genetic Correction of Mutant SOD1
Evangelos Kiskinis, Jackson Sandoe, Luis A. Williams, et al.
Cell stem cell (2014) Vol. 14, Iss. 6, pp. 781-795
Open Access | Times Cited: 427
Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent
Koki Fujimori, Mitsuru Ishikawa, Asako Otomo, et al.
Nature Medicine (2018) Vol. 24, Iss. 10, pp. 1579-1589
Closed Access | Times Cited: 424
Induced pluripotent stem cells: the new patient?
Milena Bellin, Maria C. Marchetto, Fred H. Gage, et al.
Nature Reviews Molecular Cell Biology (2012) Vol. 13, Iss. 11, pp. 713-726
Closed Access | Times Cited: 423
iPS cells: a game changer for future medicine
Haruhisa Inoue, N. Nagata, H. Kurokawa, et al.
The EMBO Journal (2014) Vol. 33, Iss. 5, pp. 409-417
Open Access | Times Cited: 395
Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models
Sami J. Barmada, Andrea Serio, Arpana Arjun, et al.
Nature Chemical Biology (2014) Vol. 10, Iss. 8, pp. 677-685
Open Access | Times Cited: 394
Generation and expansion of highly pure motor neuron progenitors from human pluripotent stem cells
Zhongwei Du, Hong Chen, Huisheng Liu, et al.
Nature Communications (2015) Vol. 6, Iss. 1
Open Access | Times Cited: 384
Neuronal medium that supports basic synaptic functions and activity of human neurons in vitro
Cédric Bardy, Mark van den Hurk, Tameji Eames, et al.
Proceedings of the National Academy of Sciences (2015) Vol. 112, Iss. 20
Open Access | Times Cited: 358
Microphysiological 3D model of amyotrophic lateral sclerosis (ALS) from human iPS-derived muscle cells and optogenetic motor neurons
Tatsuya Osaki, Sebastien G. M. Uzel, Roger D. Kamm
Science Advances (2018) Vol. 4, Iss. 10
Open Access | Times Cited: 351
Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy
Andrea Serio, Bilada Bilican, Sami J. Barmada, et al.
Proceedings of the National Academy of Sciences (2013) Vol. 110, Iss. 12, pp. 4697-4702
Open Access | Times Cited: 341
Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS
Kathrin Meyer, Laura Ferraiuolo, Carlos J. Miranda, et al.
Proceedings of the National Academy of Sciences (2013) Vol. 111, Iss. 2, pp. 829-832
Open Access | Times Cited: 324
Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development
Peter Karagiannis, Kazutoshi Takahashi, Megumu K. Saito, et al.
Physiological Reviews (2018) Vol. 99, Iss. 1, pp. 79-114
Open Access | Times Cited: 306
Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience
Jérôme Mertens, Maria C. Marchetto, Cédric Bardy, et al.
Nature reviews. Neuroscience (2016) Vol. 17, Iss. 7, pp. 424-437
Open Access | Times Cited: 285
A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells
Matthew F. Burkhardt, Fernando J. Martínez, Sarah Wright, et al.
Molecular and Cellular Neuroscience (2013) Vol. 56, pp. 355-364
Open Access | Times Cited: 273
Human iPSC-derived motoneurons harbouring TARDBP or C9ORF72 ALS mutations are dysfunctional despite maintaining viability
Anna‐Claire Devlin, Karen Burr, Shyamanga Borooah, et al.
Nature Communications (2015) Vol. 6, Iss. 1
Open Access | Times Cited: 265
Current status of pluripotent stem cells: moving the first therapies to the clinic
Erin A. Kimbrel, Robert Lanza
Nature Reviews Drug Discovery (2015) Vol. 14, Iss. 10, pp. 681-692
Closed Access | Times Cited: 250
Investigating human disease using stem cell models
Jared Sterneckert, Peter Reinhardt, Hans R. Schöler
Nature Reviews Genetics (2014) Vol. 15, Iss. 9, pp. 625-639
Closed Access | Times Cited: 238
Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells
Su‐Mi Choi, Yonghak Kim, Joong Sup Shim, et al.
Hepatology (2013) Vol. 57, Iss. 6, pp. 2458-2468
Open Access | Times Cited: 234
TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTD
Matthew A. White, Eosu Kim, Amanda Duffy, et al.
Nature Neuroscience (2018) Vol. 21, Iss. 4, pp. 552-563
Open Access | Times Cited: 233
The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis
Keiko Imamura, Yuishin Izumi, Akira Watanabe, et al.
Science Translational Medicine (2017) Vol. 9, Iss. 391
Open Access | Times Cited: 228
Page 1 - Next Page

Scroll to top